Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04150744
What this trial is testing

RFA Plus Carrizumab vs Carrizumab Alone for HCC

Who this might be right for
Tumor ImmunityImmunosuppressionRadiofrequency Ablation
Second Affiliated Hospital, Zhejiang University, School of Medicine 120
Early research (Phase 1)Looking for participantsNCT04282044
What this trial is testing

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Who this might be right for
Solid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more
BioEclipse Therapeutics 60
Large-scale testing (Phase 3)Active Not RecruitingNCT05198609
What this trial is testing

Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 214
Not applicableUnknownNCT06070636
What this trial is testing

BTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma

Who this might be right for
Liver DiseasesHepatocellular CarcinomaImmunotherapy+2 more
Sun Yat-sen University 30
Not applicableApproved For MarketingNCT02436044
What this trial is testing

HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC

Who this might be right for
Hepatocellular CarcinomaInjury; Blood Vessel, Hepatic, Artery
Ming Zhao
Not applicableUnknownNCT03739164
What this trial is testing

Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)

Who this might be right for
Liver CancerLiver TumorHepatocellular Carcinoma+1 more
Florida Hospital Tampa Bay Division 10
Very early researchUnknownNCT05152498
What this trial is testing

Fu Zheng Jie Du Hua Yu Principle For Treatment Of Severe HBV Related Hepatocellular Carcinoma (FZJDHYPFTOSHBVHCC)

Who this might be right for
Hepatocellular Carcinoma
Beijing Ditan Hospital 142
Not applicableLooking for participantsNCT07345247
What this trial is testing

RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study

Who this might be right for
Liver Cancer, Adult
Ankara University 150
Testing effectiveness (Phase 2)WithdrawnNCT05327738
What this trial is testing

Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+2 more
OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)WithdrawnNCT00003714
What this trial is testing

Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer

Who this might be right for
Liver CancerMetastatic Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03124498
What this trial is testing

Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA

Who this might be right for
Hepatocellular Carcinoma
Chuan An Biotechnology Co., Ltd. 55
Not applicableStudy completedNCT02724358
What this trial is testing

Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1

Who this might be right for
Hepatocellular CarcinomaTACENotch1+1 more
Eastern Hepatobiliary Surgery Hospital 320
Testing effectiveness (Phase 2)Study completedNCT00004248
What this trial is testing

Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)WithdrawnNCT01432314
What this trial is testing

Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Asan Medical Center
Early research (Phase 1)Study completedNCT03006926
What this trial is testing

A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eisai Co., Ltd. 104
Large-scale testing (Phase 3)WithdrawnNCT01327521
What this trial is testing

Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Albert Koong
Not applicableLooking for participantsNCT05534906
What this trial is testing

The Detection of Small Early Liver Cancer With Natural History Follow up

Who this might be right for
Hepatocellular Carcinoma
University of Oxford 250
Not applicableNot Yet RecruitingNCT07088133
What this trial is testing

Clinical Trials of the Hepatitis B Sandwich Combination Therapy for Treating Patients Infected With Hepatitis B Virus

Who this might be right for
HBV InfectionHCC - Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 12
Large-scale testing (Phase 3)Study completedNCT03713593
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 794
Not applicableLooking for participantsNCT04946773
What this trial is testing

Deep Liver Phenotyping and Immunology Study

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinoma
University of Oxford 100
Next Page